Post

India Joins Nanotech-Enabled Drug Delivery Market

India Joins Nanotech-Enabled Drug Delivery Market

India’s National Institute of Pharmaceutical Education and Research (NIPER) located at Mohali, in the northern state of Punjab, has been able to manufacture raw material for generating nanocrystal-based medicines. The U.S. and Ireland are other countries where this capability exists.

NIPER has obtained an Indian patent for the technology and has applied for the U.S. and the European patents. The technology will cut the cost of such drugs by almost half, claim experts who have developed the technology in NIPER, reports The Times of India. NIPER’s process still remains in lab trials, but the institution has entered a development and commercialization agreement with  Indian Windlas Biotech.

Dr. K. K. Bhutani acting director of NIPER said, “Unlike the available and patented technology abroad, the indigenous process generates nanocrystals directly as a solid powder, rather than as a nano-suspension in liquid that has to be subsequently converted into a solid. This has helped in cutting down the cost of generating nanocrystal raw material and opening further competition in the pharmaceutical drug development market.”

Share

About Amritt

Who We Are

Small or big, your business will love our financial help and business consultations! We are happy when our clients are too… Actually, this is quite simple to achieve – because each time we help them in sorting out different accounting intricacies or save the day before filing the taxes, they are happy indeed! And so are we.   

We have over Twenty years of experience helping our clients succeed in India
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Blog
Page
Dictionary
Comparisons
Capabilities
India Business Guide
Services
Private
Speaking
Insights
White Papers
News
Newsletters
Clients
Case Studies
Companies In India
Webinars
Presentations
Industries